ArticleNature communications2022

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.

S Mouron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.